Bayer's ‘Scary Number’ to Come Down at Appeal, Analysts Say
- Overall settlements could still rise to $10 billion, BI says
- Probability of Bayer becoming a takeover target seen rising
This article is for subscribers only.
Bayer AG fell as much as 5% after being ordered to pay $2 billion in damages to a couple who said they got cancer as a result of using its Roundup weedkiller. Analysts expect the number will probably come down at appeal, though the company faces other similar claims, increasing its litigation risk. Meanwhile, the probability of Bayer becoming a target for activist investors or a takeover target is rising, according to a Baader Helvea analyst.
Earlier: